Cargando…

Targeted BRD4 protein degradation by dBET1 ameliorates acute ischemic brain injury and improves functional outcomes associated with reduced neuroinflammation and oxidative stress and preservation of blood–brain barrier integrity

Bromodomain-containing protein 4 (BRD4), a member of the bromodomain and extra-terminal domain (BET) protein family, plays a crucial role in regulating inflammation and oxidative stress that are tightly related to stroke development and progression. Consequently, BRD4 blockade has attracted increasi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Lei, Yang, Changjun, Lavayen, Bianca P., Tishko, Ryland J., Larochelle, Jonathan, Candelario-Jalil, Eduardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237998/ https://www.ncbi.nlm.nih.gov/pubmed/35761277 http://dx.doi.org/10.1186/s12974-022-02533-8

Ejemplares similares

The BRD4 Inhibitor dBET57 Exerts Anticancer Effects by Targeting Superenhancer-Related Genes in Neuroblastoma
por: Jia, Si-Qi, et al.
Publicado: (2022)

Receptor-interacting protein kinase 2 (RIPK2) profoundly contributes to post-stroke neuroinflammation and behavioral deficits with microglia as unique perpetrators
por: Larochelle, Jonathan, et al.
Publicado: (2023)

A Novel BRD Family PROTAC Inhibitor dBET1 Exerts Great Anti-Cancer Effects by Targeting c-MYC in Acute Myeloid Leukemia Cells
por: Zhang, Kunlong, et al.
Publicado: (2022)

Role of BET Proteins in Inflammation and CNS Diseases
por: Liu, Lei, et al.
Publicado: (2021)

The BET PROTAC inhibitor dBET6 protects against retinal degeneration and inhibits the cGAS-STING in response to light damage
por: Zhu, Xingfei, et al.
Publicado: (2023)

Hitting two oncogenic machineries in cancer cells: cooperative effects of the multi-kinase inhibitor ponatinib and the BET bromodomain blockers JQ1 or dBET1 on human carcinoma cells
por: Bauer, Karin, et al.
Publicado: (2018)

The BET/BRD inhibitor JQ1 improves brain plasticity in WT and APP mice
por: Benito, E, et al.
Publicado: (2017)

Neurovascular protection by adropin in experimental ischemic stroke through an endothelial nitric oxide synthase-dependent mechanism
por: Yang, Changjun, et al.
Publicado: (2021)

Genetic Deletion or Pharmacological Inhibition of Cyclooxygenase-2 Reduces Blood-Brain Barrier Damage in Experimental Ischemic Stroke
por: Yang, Changjun, et al.
Publicado: (2020)

BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis
por: Roberts, Thomas C., et al.
Publicado: (2017)

Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4
por: Zengerle, Michael, et al.
Publicado: (2015)

Spatiotemporal Changes in P-glycoprotein Levels in Brain and Peripheral Tissues Following Ischemic Stroke in Rats
por: DeMars, Kelly M, et al.
Publicado: (2017)

BET Bromodomain Proteins Brd2, Brd3 and Brd4 Selectively Regulate Metabolic Pathways in the Pancreatic β-Cell
por: Deeney, Jude T., et al.
Publicado: (2016)

Fluorometric immunocapture assay for the specific measurement of matrix metalloproteinase-9 activity in biological samples: application to brain and plasma from rats with ischemic stroke
por: Hawkins, Kimberly E, et al.
Publicado: (2013)

A role for cyclooxygenase-1 in β-amyloid-induced neuroinflammation
por: Candelario-Jalil, Eduardo
Publicado: (2009)

Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function
por: Cribbs, Adam P., et al.
Publicado: (2021)

BRD4: A BET(ter) target for the treatment of AML?
por: Valent, Peter, et al.
Publicado: (2014)

Age-Dependent Decrease in Adropin is Associated with Reduced Levels of Endothelial Nitric Oxide Synthase and Increased Oxidative Stress in the Rat Brain
por: Yang, Changjun, et al.
Publicado: (2018)

Detrimental role of the EP1 prostanoid receptor in blood-brain barrier damage following experimental ischemic stroke
por: Frankowski, Jan C., et al.
Publicado: (2015)

BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice
por: Korb, Erica, et al.
Publicado: (2015)

BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells
por: Coudé, Marie-Magdelaine, et al.
Publicado: (2015)

BRD9 regulates interferon-stimulated genes during macrophage activation via cooperation with BET protein BRD4
por: Ahmed, Nasiha S., et al.
Publicado: (2021)

Ischemic Stroke Impacts the Gut Microbiome, Ileal Epithelial and Immune Homeostasis
por: Ge, Yong, et al.
Publicado: (2022)

Protective Effects of L-902,688, a Prostanoid EP4 Receptor Agonist, against Acute Blood-Brain Barrier Damage in Experimental Ischemic Stroke
por: DeMars, Kelly M., et al.
Publicado: (2018)

4-Ethylguaiacol Modulates Neuroinflammation and Promotes Heme Oxygenase-1 Expression to Ameliorate Brain Injury in Ischemic Stroke
por: Weng, Wen-Tsan, et al.
Publicado: (2022)

Spatiotemporal Correlations between Blood-Brain Barrier Permeability and Apparent Diffusion Coefficient in a Rat Model of Ischemic Stroke
por: Taheri, Saeid, et al.
Publicado: (2009)

BrdU-positive cells in the neonatal mouse hippocampus following hypoxic-ischemic brain injury
por: Bartley, John, et al.
Publicado: (2005)

Resistance to BET inhibitors in lung adenocarcinoma is mediated by casein kinase phosphorylation of BRD4
por: Calder, Jack, et al.
Publicado: (2021)

Phosphorylation-dependent BRD4 dimerization and implications for therapeutic inhibition of BET family proteins
por: Malvezzi, Francesca, et al.
Publicado: (2021)

Optimized Brain Extraction for Pathological Brains (optiBET)
por: Lutkenhoff, Evan S., et al.
Publicado: (2014)

Neuroinflammation in Post-Ischemic Neurodegeneration of the Brain: Friend, Foe, or Both?
por: Pluta, Ryszard, et al.
Publicado: (2021)

Zebrafish brd2a and brd2b are paralogous members of the bromodomain-ET (BET) family of transcriptional coregulators that show structural and expression divergence
por: DiBenedetto, Angela J, et al.
Publicado: (2008)

Early electroacupuncture treatment ameliorates neuroinflammation in rats with traumatic brain injury
por: Tang, Wei-Chen, et al.
Publicado: (2016)

Inducible In Vivo Silencing of Brd4 Identifies Potential Toxicities of Sustained BET Protein Inhibition
por: Bolden, Jessica E., et al.
Publicado: (2014)

The BET Family Member BRD4 Interacts with OCT4 and Regulates Pluripotency Gene Expression
por: Wu, Tao, et al.
Publicado: (2015)

A novel SIRT6 activator ameliorates neuroinflammation and ischemic brain injury via EZH2/FOXC1 axis
por: He, Tailin, et al.
Publicado: (2021)

Targeting resolution of neuroinflammation after ischemic stroke with a lipoxin A(4) analog: Protective mechanisms and long‐term effects on neurological recovery
por: Hawkins, Kimberly E., et al.
Publicado: (2017)

Effects of nimesulide on kainate-induced in vitro oxidative damage in rat brain homogenates
por: Candelario-Jalil, Eduardo, et al.
Publicado: (2003)

Neuroinflammation and brain–peripheral interaction in ischemic stroke: A narrative review
por: Cheng, Wenjing, et al.
Publicado: (2023)

Selective Inhibition of Janus Kinase 3 Has No Impact on Infarct Size or Neurobehavioral Outcomes in Permanent Ischemic Stroke in Mice
por: DeMars, Kelly M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mm1t4p83l2611ncrm0rma6lsf7